XML 25 R11.htm IDEA: XBRL DOCUMENT
v3.19.1

Share-Based Payments | 5 Months Ended
--- | ---
Feb. 09, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-Based Payments | Note B – Share-Based Payments AutoZone maintains the Amended 2011 Equity Plan, which provides equity-based compensation to non-employee directors and eligible employees for their service to AutoZone, its subsidiaries or affiliates. The Company recognizes compensation expense for share-based payments based on the fair value of the awards at the grant date. Share-based payments include stock option grants, restricted stock grants, restricted stock unit grants and the discount on shares sold to employees under share purchase plans. Additionally, directors’ fees are paid in restricted stock units with value equivalent to the value of shares of common stock as of the grant date. The change in fair value of liability-based stock awards is also recognized in share-based compensation expense. Stock Options: The Company made stock option grants of 172,588 shares during the twenty-four week period ended February 9, 2019, and granted options to purchase 283,290 shares during the comparable prior year period. The weighted average fair value of the stock option awards granted during the twenty-four week periods ended February 9, 2019 and February 10, 2018, using the Black-Scholes-Merton multiple-option pricing valuation model, was $208.33 and $128.99 per share, respectively, using the following weighted average key assumptions:
|  | Twenty-Four Weeks Ended |
|  | February 9, 2019 |  |  | February 10, 2018 |
Expected price volatility |  |  | 21 | % |  |  | 20 | %
Risk-free interest rate |  |  | 3.0 | % |  |  | 1.9 | %
Weighted average expected lives (in years) |  |  | 5.6 |  |  |  | 5.1 |
Forfeiture rate |  |  | 10 | % |  |  | 10 | %
Dividend yield |  |  | 0 | % |  |  | 0 | %
During the twenty-four week period ended February 9, 2019, 283,210 stock options were exercised at a weighted average exercise price of $390.26. In the comparable prior year period, 234,114 stock options were exercised at a weighted average exercise price of $278.69. Restricted Stock Units: The Company made restricted stock unit grants of 10,474 shares to eligible employees during the twenty-four week period ended February 9, 2019 and none in the comparable prior year period. The fair value of the restricted stock unit grants is the closing price of the Company’s common stock on the grant date and the grants vest ratably on an annual basis over a four-year service period. Restricted stock unit awards are payable in shares of common stock on the vesting date. Compensation expense for grants of employee restricted stock units is recognized on a straight-line basis over the four-year service period, less estimated forfeitures, which are consistent with stock option grant forfeiture assumptions. The weighted average fair value per restricted stock unit granted was $ 772.80 . As of February 9, 2019, total unrecognized stock-based compensation expense related to nonvested restricted stock unit awards, net of estimated forfeitures, was approximately $6.6 million, before income taxes, which we expect to recognize over an estimated weighted average period of 4.0 years. None of the restricted stock units were vested as of February 9, 2019. Total share-based compensation expense (a component of Operating, selling, general and administrative expenses) was $11.0 million for the twelve week period ended February 9, 2019, and $12.7 million for the comparable prior year period. Total share-based compensation expense (a component of Operating, selling, general and administrative expenses) was $21.6 million for the twenty-four week period ended February 9, 2019, and $23.8 million for the comparable prior year period. For the twelve week period ended February 9, 2019, 170,069 stock options were excluded from the diluted earnings per share computation because they would have been anti-dilutive. For the comparable prior year period, 609,435 anti-dilutive shares were excluded from the dilutive earnings per share computation. There were 188,999 anti-dilutive shares excluded from the diluted earnings per share computation for the twenty-four week period ended February 9, 2019, and 844,912 anti-dilutive shares excluded for the comparable prior year period. See AutoZone’s Annual Report on Form 10-K for the year ended August 25, 2018, for a discussion regarding the methodology used in developing AutoZone’s assumptions to determine the fair value of the option awards and a description of AutoZone’s Amended and Restated 2011 Equity Incentive Award Plan, the 2011 Director Compensation Program and the 2014 Director Compensation Plan.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration